This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Revolution Medicines, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jacqueline Smith: Innovator in Cancer Treatment
Introduction
Jacqueline Smith is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents.
Latest Patents
Jacqueline holds a patent for SHP2 inhibitor compositions and methods for treating cancer. This invention focuses on compositions and methods for treating or preventing diseases with inhibitors of SHP2, either alone or in combination with other therapeutic agents such as RAS pathway inhibitors. The patent also outlines methods for establishing appropriate treatment plans based on the expression of biomarkers indicative of SHP2 inhibitor sensitivity, as well as methods for determining sensitivity to a SHP2 inhibitor based on the phosphorylation status of SHP2. She has 1 patent to her name.
Career Highlights
Jacqueline is currently associated with Revolution Medicines, Inc., where she continues to advance her research in cancer therapies. Her work is pivotal in developing new treatment options that could potentially improve patient outcomes.
Collaborations
Some of her notable coworkers include Robert J Nichols and Mark A Goldsmith, who contribute to her research endeavors and collaborative projects.
Conclusion
Jacqueline Smith's innovative work in developing SHP2 inhibitors represents a significant advancement in cancer treatment. Her contributions are vital to the ongoing fight against cancer, and her research may lead to more effective therapies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile